Join

Compare · CHFS vs TMDX

CHFS vs TMDX

Side-by-side comparison of CHF Solutions, Inc. (CHFS) and TransMedics Group Inc. (TMDX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CHFS and TMDX operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
  • TMDX carries a market cap of $3.25B.
  • TMDX has hit the wire 5 times in the past 4 weeks while CHFS has been quiet.
  • TMDX has more recent analyst coverage (19 ratings vs 0 for CHFS).
MetricCHFSTMDX
Company
CHF Solutions, Inc.
TransMedics Group Inc.
Price
-
-
Market cap
-
$3.25B
1M return
-
+25.93%
1Y return
-
-18.71%
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NASDAQ
NASDAQ
IPO
n/a
2019
News (4w)
0
5
Recent ratings
0
19
TMDX

TransMedics Group Inc.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.

Latest CHFS

Latest TMDX